Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats.
BACKGROUND
Sleep and cognitive impairments are two of the most prevalent neuropsychiatric disorders in the aged population. Age-related memory dysfunctions can result from alterations in sleep/wake circadian rhythm. However, the underlying mechanism of these alterations is unknown. Here, we demonstrate the role of alterations in brain steroid levels in age-related sleep-dependent memory impairment in rats.


METHODS
Sleep/wake circadian activity and spatial memory performance were evaluated in adult, middle-aged, and aged rats, and steroid levels were measured in brain structures involved in mediating sleep-dependent memory processes using gas chromatography/mass spectrometry. The causal relationship between circadian activity and allopregnanolone levels was assessed using an inhibitor of allopregnanolone synthesis (indomethacin).


RESULTS
Similar to observations in humans, a subpopulation of middle-aged and aged rats show flattened amplitude of circadian activity associated with impaired spatial long-term memory performance. Sleep-dependent memory dysfunction was associated with a low level of allopregnanolone in the hypothalamus, pedunculopontine nucleus, and ventral striatum. Inhibition of allopregnanolone synthesis in young rats decreased allopregnanolone in the hypothalamus and produced flattened amplitude of circadian activity similar to aged rats.


CONCLUSIONS
These findings identify brainstem and basal forebrain allopregnanolone as an essential endogenous substrate involved in mediating sleep-dependent memory function in young and aged rats. Allopregnanolone may play a critical role in preserving individuals from age-induced alterations in sleep and memory processes and may represent a novel target for attenuating age-related declines in sleep and memory.
George
Olivier
O
Institut National de la Sante et de la Recherche Medical (INSERM), Unite 862, Neurocenter Magendie, Physiopathology of Addiction Group, Bordeaux, France. ogeorge@scripps.edu
Vallée
Monique
M
Vitiello
Sergio
S
Le Moal
Michel
M
Piazza
Pier-Vincenzo
PV
Mayo
Willy
W
D000375:Aging / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004195:Disease Models, Animal; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008569:Memory Disorders / Q000150:complications / Q000378:metabolism*; D011280:Pregnanolone / Q000097:blood / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D020178:Sleep Disorders, Circadian Rhythm / Q000150:complications / Q000378:metabolism*; D013256:Steroids / Q000097:blood / Q000378:metabolism
D013256:Steroids; D011280:Pregnanolone; D007213:Indomethacin
Alcohol Clin Exp Res. 2002 Nov;26(11):1747-51
12436065
Exp Gerontol. 2005 Apr;40(4):279-85
15820608
Neurobiol Learn Mem. 2006 Sep;86(2):150-9
16580234
Curr Alzheimer Res. 2006 Feb;3(1):11-7
16472197
J Pharmacol Exp Ther. 1997 Sep;282(3):1213-8
9316828
Anal Chem. 2003 Nov 1;75(21):5835-46
14588024
Trends Cogn Sci. 2007 Oct;11(10):442-50
17905642
Endocrinology. 2006 Jan;147(1):179-90
16223859
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S143-61
19656632
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1567-71
1531874
Brain Res Brain Res Rev. 2001 Nov;37(1-3):301-12
11744095
Int Rev Neurobiol. 2001;46:97-115
11599313
Int Rev Neurobiol. 2001;46:273-320
11599303
J Neurosci. 2002 Feb 15;22(4):1436-42
11850470
Neurosci Biobehav Rev. 1995 Winter;19(4):553-71
8684716
J Neurosci. 2004 Jul 21;24(29):6446-56
15269254
Neuropsychopharmacology. 2001 Oct;25(4):576-84
11557171
Biopharm Drug Dispos. 1999 Sep;20(6):277-84
10701698
Methods Find Exp Clin Pharmacol. 1990 Nov;12(9):641-3
2084459
Brain Res. 1995 Oct 23;696(1-2):113-20
8574658
J Chromatogr B Biomed Sci Appl. 2000 Mar 10;739(2):301-12
10755374
J Neuroendocrinol. 2004 Jan;16(1):58-63
14962077
Sleep Med Rev. 2002 Feb;6(1):45-54
12531141
Neuron. 2002 Dec 19;36(6):1183-94
12495631
Brain Res. 1993 Apr 2;607(1-2):324-8
8386975
Lancet Neurol. 2003 Jan;2(1):15-21
12849297
J Neurosci. 1999 May 15;19(10):4090-101
10234037
J Neurosci. 2004 Feb 11;24(6):1416-27
14960614
Psychopharmacology (Berl). 2006 Jun;186(3):402-13
16416333
Sleep. 2003 May 1;26(3):342-92
12749557
J Neurosci Methods. 1980 Dec;3(2):129-49
6110810
Science. 2001 Nov 2;294(5544):1052-7
11691983
J Biol Chem. 1985 Dec 5;260(28):15266-72
2933398
Science. 1996 Mar 29;271(5257):1870-3
8596957
J Sleep Res. 1993 Mar;2(1):28-33
10607067
Methods Find Exp Clin Pharmacol. 2007 Jun;29(5):315-20
17805432
Annu Rev Psychol. 2006;57:139-66
16318592
J Neurophysiol. 1995 Jul;74(1):464-9
7472348
Brain Res. 2000 Mar 10;858(2):371-9
10708689
Brain Res. 2002 May 3;934(2):125-31
11955475
Neuroscience. 2004;123(2):349-59
14698743
Nat Rev Neurosci. 2002 Sep;3(9):679-93
12209117
Exp Gerontol. 2000 Dec;35(9-10):1229-37
11113604
Restor Neurol Neurosci. 2004;22(1):19-31
15096691
Eur J Neurosci. 2004 Sep;20(6):1604-12
15355327
Exp Gerontol. 2004 Nov-Dec;39(11-12):1695-704
15582285
Psychoneuroendocrinology. 1998 Nov;23(8):963-87
9924747
Science. 2001 Nov 2;294(5544):1048-52
11691982
Brain Res Dev Brain Res. 2004 Oct 15;153(1):13-7
15464213
Anal Biochem. 2000 Dec 1;287(1):153-66
11078595
Brain Res Brain Res Rev. 2001 Nov;37(1-3):116-32
11744080
Neuroscience. 2006 May 12;139(2):651-9
16457954
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15593-8
18832172
Neurobiol Aging. 2006 Dec;27(12):1848-58
16316709
Neurobiol Learn Mem. 2006 Jul;86(1):35-46
16529958
Horm Behav. 1999 Feb;35(1):1-8
10049597
Prog Neurobiol. 2003 Sep;71(1):43-8
14611866
Learn Mem. 2002 Jan-Feb;9(1):41-7
11917005
Neuroscience. 2007 Feb 23;144(4):1293-304
17187935
Am J Geriatr Psychiatry. 2006 Feb;14(2):95-103
16473973
Int J Pharm. 2004 Feb 11;270(1-2):149-66
14726131
Eur J Neurosci. 2005 Jun;21(12):3403-14
16026478